⌘K

Login Start Free

Home/Filings/4/0001099910-12-000042

4//SEC Filing

Lundquist David J. 4

Accession 0001099910-12-000042

CIK 0001126234other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:52 PM ET

Size

11.8 KB

Accession

0001099910-12-000042

Insider Transaction Report

Form 4

Period: 2012-03-01

NEWLINK GENETICS CORP[NLNK]

Lundquist David J.

Director

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2012-03-01−11,904→ 0 total
Exercise: $2.10From: 2011-03-31Exp: 2018-07-15→ Common Stock (11,904 underlying)
Exercise/Conversion
Common Stock
2012-03-01$2.10/sh+7,142$14,998→ 19,046 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-03-01−7,142→ 0 total
Exercise: $2.10From: 2009-10-26Exp: 2018-08-05→ Common Stock (7,142 underlying)
Exercise/Conversion
Common Stock
2012-03-01$2.10/sh+11,904$24,998→ 11,904 total

Holdings

Common Stock
(indirect: -)
43,815
Common Stock
(indirect: -)
43,815

Footnotes (2)

[F1]These shares belong to the David J. Lundquist 2011 Exempt Revocable Trust.
[F2]These shares belong to the David J. Lundquist 2011 Nonexempt Revocable Trust.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NEWLINK GENETICS CORP

CIK 0001126234

Entity typeother

Related Parties

1

filerCIK 0001512133

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 5:52 PM ET
Size: 11.8 KB

View on SEC.gov